Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01555619 · ClinicalTrials.gov registry record
Quadripolar Pacing Post Approval Study
A clinical trial of Heart Failure, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 1,971
- Enrollment target
- 20
- Study locations
NCT01555619 is a study of Heart Failure that has completed, run by Abbott Medical Devices. The registered enrollment target is 1,971 participants, roughly in line with the 2,044-participant average among 397 other Heart Failure trials with a reported enrollment target. The trial reports 20 study locations across 5 states.
The verdict
NCT01555619, a study of Heart Failure, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 1,971 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this post-approval study is to evaluate the acute and chronic performance of a Quadripolar CRT-D device system in a patient population indicated for cardiac resynchronization therapy (CRT).
Conditions Studied
Interventions
- DEVICE CRT-D System
Study Locations (20)
California
- Comprehensive Cardiovascular - Bakersfield
- Scripps Green Hospital - La Jolla
- USC Unversity Hospital - Los Angeles
- Fogarty Institute - Mountain View
- Premier Cardiology, Inc. - Newport Beach
- Cardiac Rhythm Specialists, Inc. - Northridge
- St. Joseph Heritage Medical Group - Orange
- Regional Cardiology Associates - Sacramento
- St. Joseph's Medical Center - Stockton
- Cardiology Associates Medical Group, Inc. - Ventura
Florida
- Florida Electrophysiology Associates - Atlantis
- Yoel R. Vivas, MD - Boynton Beach
- Jorge Diaz - Lake Mary
- Naples Heart Rhythm Specialists - Naples
Alabama
- Cardiology, P.C. - Birmingham
- Heart Center Research, LLC/Research Center - Huntsville
- Southeastern Cardiology Consultants PC - Montgomery
Arkansas
- Washington Regional Medical Center - Fayetteville
- Arkansas Heart Hospital - Little Rock
Arizona
- Arizona Arrhythmia Research Center - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,971 participants |
| Start Date | 2012-02-15 |
| Est. Completion | 2019-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01555619
The ClinicalTrials.gov registry entry for NCT01555619 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,971 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 2,044-participant average among 397 other Heart Failure trials with a reported enrollment target. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which CRT-D System is the first listed.
NCT01555619 reports 20 study locations spanning 5 distinct geographic areas - top geographies include California, Florida, Alabama.
Frequently Asked Questions
What is clinical trial NCT01555619 about?
NCT01555619 is a clinical study titled "Quadripolar Pacing Post Approval Study". The purpose of this post-approval study is to evaluate the acute and chronic performance of a Quadripolar CRT-D device system in a patient population indicated for cardiac resynchronization therapy (CRT).
What is the current status of trial NCT01555619?
This trial is currently completed. The enrollment target is 1,971 participants. The study started on 2012-02-15. Estimated completion is 2019-02-28.
What conditions does trial NCT01555619 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT01555619?
The interventions under investigation include: CRT-D System (DEVICE).
Who is sponsoring clinical trial NCT01555619?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01555619 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.